Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial

被引:695
作者
Kang, HJ
Kim, HS
Zhang, SY
Park, KW
Cho, HJ
Koo, BK
Kim, YJ
Lee, DS
Sohn, DW
Han, KS
Oh, BH
Lee, MM
Park, YB
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Clin Res Inst, Cardiovasc Lab, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea
[4] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea
[5] Seoul Natl Univ Hosp, Dept Lab Med, Seoul 110744, South Korea
关键词
D O I
10.1016/S0140-6736(04)15689-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Bone-marrow stem-cell transplantation has been shown to improve cardiac function in patients with myocardial infarction. We examined the feasibility and efficacy of granulocyte-colony stimulating factor (G-CSF) therapy and subsequent intracoronary infusion of collected peripheral blood stem-cells (PBSCs) in such patients. Methods We prospectively randomised 27 patients with myocardial infarction who underwent coronary stenting for the culprit lesion of infarction into three groups; cell infusion (n=10), G-CSF alone (n=10), and control group (n=7). Changes in left ventricular systolic function and perfusion were assessed after 6 months. By December, 2003, seven patients from the cell infusion group, three from the G-CSF group, and one from the control group had been assessed. Findings G-CSF injection and intracoronary infusion of the mobilised PBSC did not aggravate inflammation and ischaermia during the periprocedural period. Exercise capacity (mean treadmill exercise time: 450 s [SD 178] at baseline vs 578 s [168] at 6 months' follow-up, p=0.004), myocardial perfusion (perfusion defect 11.6% [9.6] vs 5.3% [5.0], p=0.020) and systolic function (left ventricular ejection fraction 48.7% [8.3] vs 55.1% [7.4], p=0.005) improved significantly in patients who received cell infusion. However, we noted an unexpectedly high rate of in-stent restenosis at culprit lesion in patients who received G-CSF, and therefore we stopped enrolment. Interpretation G-CSF therapy with intracoronary infusion of PBSC showed improved cardiac function, and promoted angiogenesis in patients with myocardial infarction. However, aggravation of restenosis could be a serious problem. In future studies with G-CSF based stem-cell therapy, patients should be carefully monitored for unexpected effects.
引用
收藏
页码:751 / 756
页数:6
相关论文
共 19 条
[1]   Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals [J].
Anderlini, P ;
Przepiorka, D ;
Champlin, R ;
Korbling, M .
BLOOD, 1996, 88 (08) :2819-2825
[2]  
[Anonymous], 1999, COBE SPECTR APH SYST
[3]   Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction -: (TOPCARE-AMI) [J].
Assmus, B ;
Schächinger, V ;
Teupe, C ;
Britten, M ;
Lehmann, R ;
Döbert, N ;
Grünwald, F ;
Aicher, A ;
Urbich, C ;
Martin, H ;
Hoelzer, D ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2002, 106 (24) :3009-3017
[4]  
BENSINGER W, 1993, BLOOD, V81, P3158
[5]   Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor [J].
Cavallaro, AM ;
Lilleby, K ;
Majolino, I ;
Storb, R ;
Appelbaum, FR ;
Rowley, SD ;
Bensinger, WI .
BONE MARROW TRANSPLANTATION, 2000, 25 (01) :85-89
[6]   Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation [J].
Cho, HJ ;
Kim, HS ;
Lee, MM ;
Kim, DH ;
Yang, HJ ;
Hur, J ;
Hwang, KK ;
Oh, S ;
Choi, YJ ;
Chae, IH ;
Oh, BH ;
Choi, YS ;
Walsh, K ;
Park, YB .
CIRCULATION, 2003, 108 (23) :2918-2925
[7]  
ELLIS SG, 2003, MOL CARD S 1 MYOG SE
[8]  
Fritsch G, 1996, BONE MARROW TRANSPL, V17, P169
[9]  
GERMANO G, 1995, J NUCL MED, V36, P2138
[10]  
Hill JM, 2003, CIRCULATION, V108, P478